Ładuje się......
Molecular targeted therapies of renal cell carcinoma considering life stage of the patient: Two case reports
Molecular targeted therapies have markedly improved the prognosis of metastatic renal cell carcinoma (RCC) and patients are able to receive specific treatments depending on their condition. The cases of two patients who presented with large RCC with very different statuses were examined in the curre...
Zapisane w:
| Wydane w: | Exp Ther Med |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
D.A. Spandidos
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5844110/ https://ncbi.nlm.nih.gov/pubmed/29556268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.5882 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|